Article metrics

other Versions

Download PDFPDF

ATARI trial: ATR inhibitor in combination with olaparib in gynecological cancers with ARID1A loss or no loss (ENGOT/GYN1/NCRI)

 

Online download statistics by month:

Online download statistics by month: September 2021 to October 2024

AbstractFullPdf
Sep 2021456455166
Oct 2021383373119
Nov 2021728726135
Dec 2021748740523
Jan 202213171313949
Feb 2022135813461146
Mar 202233733079
Apr 2022116311661066
May 2022174917451518
Jun 2022133813441093
Jul 202227527363
Aug 202220619575
Sep 202221821274
Oct 202221620771
Nov 202213713254
Dec 202213712837
Jan 202316817049
Feb 202324324069
Mar 202317617269
Apr 202312611651
May 2023919158
Jun 2023827839
Jul 202310410250
Aug 202313312739
Sep 20231049431
Oct 202311711845
Nov 202312911643
Dec 202313712651
Jan 20249394107
Feb 2024988937
Mar 202411511781
Apr 2024999141
May 2024868441
Jun 2024827641
Jul 2024747432
Aug 2024826948
Sep 2024817931
Oct 2024798242
Total13265130908263